ArticleMolecules (Basel, Switzerland)2025

A HER2 Specific Nanobody-Drug Conjugate: Site-Selective Bioconjugation and In Vitro Evaluation in Breast Cancer Models.

Anders H Hansen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.